Skip to main content
John  Strouboulis

Professor John Strouboulis

Chair in Molecular Erythropoiesis

Research interests

  • Biomedical and life sciences
  • Cancer
  • Pharmacy

Biography

John Strouboulis was appointed Professor and Chair in Molecular Erythropoiesis at King’s College London in 2018. He is an expert in the transcriptional and epigenetic regulation of red blood cell differentiation (or erythropoiesis) using proteomic, genomic and functional approaches. He has made important contributions in our understanding of human globin gene regulation in vivo and of key transcription factor functions in erythropoiesis. Together with clinical colleagues and human geneticists, John Strouboulis is developing a translational research programme in sickle cell disease and other red cell disorders at King's.

John did his PhD at the MRC-National Institute for Medical Research in London on the developmental regulation of the human β-globin locus and a postdoctoral fellowship at the National Institutes of Health on Polycomb Group. Subsequently, John joined the Department of Cell Biology at the Erasmus University Medical Center in Rotterdam, Netherlands, as a Marie Curie Fellow and later as a senior staff scientist. Prior to his appointment at King's, John Strouboulis was Research Professor at the Institute of Molecular Biology and Biotechnology-FORTH in Heraklion, Crete, Greece and, prior to that, he was a senior group leader at the “Alexander Fleming” Biomedical Sciences Research Center in Athens, Greece. He has been awarded EMBO and HFSPO postdoctoral fellowships and a Wellcome Senior Research Fellowship. His research is presently funded by the MRC, The European Union and Action Medical Research. His research lab has also received support by the Chartwell Cancer Trust and KCH Charity.

    Research

    Untitled design - 2021-09-30T121917.141
    Red Cell Haematology

    Red Cell Haematology

    Pericles logo
    Prenatal ThERapy for SIckle CelL disEaSe (PERICLES)

    To generate new knowledge about stakeholders' views on prenatal therapy for Sickle Cell Disease, identify ethical issues and establish protocols for support.

    Project status: Ongoing

    News

    Celebrating recent Grant and Fellowship successes for the School of Cancer & Pharmaceutical Sciences

    A comprehensive round up of recent successes for Academics across the Institute of Pharmaceutical Science and the Comprehensive Cancer Centre.

    cancer cells

    Spotlight

    Transforming the lives of people with Sickle Cell Disorder

    How a new Sickle Cell Centre for Excellence at King’s and King’s Health Partners is leading the way in tackling one of the most common genetic blood diseases...

    Image by Ed Uthman [https://creativecommons.org/licenses/by/2.0/]

      Research

      Untitled design - 2021-09-30T121917.141
      Red Cell Haematology

      Red Cell Haematology

      Pericles logo
      Prenatal ThERapy for SIckle CelL disEaSe (PERICLES)

      To generate new knowledge about stakeholders' views on prenatal therapy for Sickle Cell Disease, identify ethical issues and establish protocols for support.

      Project status: Ongoing

      News

      Celebrating recent Grant and Fellowship successes for the School of Cancer & Pharmaceutical Sciences

      A comprehensive round up of recent successes for Academics across the Institute of Pharmaceutical Science and the Comprehensive Cancer Centre.

      cancer cells

      Spotlight

      Transforming the lives of people with Sickle Cell Disorder

      How a new Sickle Cell Centre for Excellence at King’s and King’s Health Partners is leading the way in tackling one of the most common genetic blood diseases...

      Image by Ed Uthman [https://creativecommons.org/licenses/by/2.0/]